MDER (Medera) EV-to-OCF: 0.00 (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medera EV-to-OCF?

Medera MDER EV-to-OCF is 0.00 as of Sep. 22, 2026.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Medera's Enterprise Value is $0.00 Mil. Medera's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2024 was $-6.59 Mil. Therefore, Medera's EV-to-OCF for today is 0.00.

The historical rank and industry rank for Medera's EV-to-OCF or its related term are showing as below:

MDER's EV-to-OCF is not ranked *
in the Biotechnology industry.
Industry Median: -3.36
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-22), Medera's stock price is $0.00. Medera's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.000. Therefore, Medera's PE Ratio (TTM) for today is N/A.

Medera  (NAS:MDER) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medera's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/0.000
=N/A

Medera's share price for today is $0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medera's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Medera EV-to-OCF Related Terms

Medera EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Medera's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medera EV-to-OCF Chart

Medera Annual Data
Trend Dec22 Dec23
EV-to-OCF
0.00 0.00

Medera Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
EV-to-OCF 0.00 0.00 0.00 0.00

Medera EV-to-OCF Calculation

Medera's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.000/-6.594
=0.00

Medera's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medera's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2024 was $-6.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of 0.00 mean?
Medera (MDER) has a EV-to-OCF of 0.00 as of Sep. 22, 2026.
Is Medera's EV-to-OCF too high?
Medera's current EV-to-OCF is 0.00.
How does Medera's EV-to-OCF compare to ?
Medera's EV-to-OCF of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Medera's current EV-to-OCF is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medera stock overvalued right now?
Medera (MDER) has a current EV-to-OCF of 0.00. The current EV-to-OCF is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Medera (MDER), the current EV-to-OCF is 0.00 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medera Business Description

Comparable Companies
Address 6 Tide Street, 2nd Floor, Boston, MA, USA, 02210
Medera Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics for difficult-to-treat and currently incurable diseases, with a focus on cardiovascular conditions. It operates through two business arms. Novoheart, its preclinical disease modeling and drug discovery brand, provides bioengineered human mini-heart technology and related platforms used for preclinical screening and drug discovery. Sardocor, its clinical development brand, advances novel gene therapies toward the clinic, leveraging the Novoheart platform to pursue an efficient regulatory path, particularly for cardiovascular diseases. The company's customers and collaborators include pharmaceutical and biotechnology companies, academic and research institutions, and other organizations that use its human heart modeling technologies for drug testing and development. Medera generates revenue primarily through research services, technology licensing, and collaboration arrangements, while its therapeutic candidates remain in preclinical and clinical development stages.